KIRGEN
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
KIRGEN - overview
Established
2015
Location
Shanghai, Shanghai, China
Primary Industry
Medical Devices & Equipment
About
Based in Shanghai, China and founded in 2015, KIRGEN operates as a supplier of medical consumables, offering laboratory disposable consumables. The company has obtained more than 180 invention patents. 2021, KIRGEN certified as a high-tech enterprise. In May 2023, the company raised approximately CNY 100 million in a strategic investment.
KIRGEN has developed over 370 products. The company's products cover the four core areas of molecular biology, cell culture and preservation, liquid handling and in vitro diagnostics. The main products are high-end laboratory consumables and membrane products for liquid handling, molecular biology and cell storage and culture. The products can be used in basic scientific research, in vitro diagnostics, vaccines, cell therapy, antibody drugs, gene therapy and other biopharmaceutical related fields.
Current Investors
Sinopharm-CICC Capital, Huaying Investment, Addor Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Medical Supplies
Website
www.kirgen.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.